Bioactive IGF-1 release from collagen–GAG scaffold to enhance cartilage repair in vitro

Journal of Materials Science: Materials in Medicine

Volumn 26, Issue 1, 2015, Pages 1-8

  Mullen, Leanne M ^a   Best, Serena M ^a   Ghose, Siddhartha ^b   Wardale, John ^a   Rushton, Neil ^a   Cameron, Ruth E ^a  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^b TiGenix Ltd   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BODY FLUIDS; CARTILAGE; COLLAGEN; DEPOSITION; REGRESSION ANALYSIS; REPAIR; SCAFFOLDS (BIOLOGY); TISSUE ENGINEERING;

BIOLOGICAL RESPONSE; DOSE-DEPENDENT MANNER; EXTRACELLULAR MATRICES; GLYCOSAMINOGLYCANS; GROWTH FACTOR DELIVERY; INSULIN-LIKE GROWTH FACTOR-1; LOADING CONCENTRATION; PROTEOLYTIC DIGESTION;

LOADING;

CHONDROITIN 6 SULFATE; COLLAGEN; COLLAGEN TYPE 2; DECORIN; PROTEOGLYCAN; RECOMBINANT SOMATOMEDIN C; GLYCOSAMINOGLYCAN; SOMATOMEDIN C;

ARTICLE; CARTILAGE CELL; CHONDROGENESIS; COLLAGEN SYNTHESIS; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG DELIVERY DEVICE; DRUG RELEASE; EXTRACELLULAR MATRIX; HUMAN; HUMAN CELL; IN VITRO STUDY; OSTEOARTHRITIS; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROTEOGLYCAN SYNTHESIS; TISSUE SCAFFOLD; CARTILAGE; CELL CULTURE; GROWTH, DEVELOPMENT AND AGING; METABOLISM; PHYSIOLOGY;

CARTILAGE; CELLS, CULTURED; COLLAGEN TYPE II; GLYCOSAMINOGLYCANS; HUMANS; IN VITRO TECHNIQUES; INSULIN-LIKE GROWTH FACTOR I; TISSUE SCAFFOLDS;

EID: 84920862182     PISSN: 09574530     EISSN: 15734838     Source Type: Journal    
DOI: 10.1007/s10856-014-5325-y     Document Type: Article

References (56)

1. Aigner T, Hemmel M, et al. Apoptotic cell death is not a widespread phenomenon in normal aging and osteoarthritis human articular knee cartilage: a study of proliferation, programmed cell death (apoptosis), and viability of chondrocytes in normal and osteoarthritic human knee cartilage. Arthritis Rheum. 2001;44(6):1304–12.
2. Aigner T, Vornehm SI, et al. Suppression of cartilage matrix gene expression in upper zone chondrocytes of osteoarthritic cartilage. Arthritis Rheum. 1997;40(3):562–9.
3. Bhavsar D, Shettko D, et al. Encircling the tendon repair site with collagen–GAG reduces the formation of postoperative tendon adhesions in a chicken flexor tendon model. J Surg Res. 2010;159(2):765–71.
4. Buckwalter JA, Mankin HJ. Articular cartilage.1. Tissue design and chondrocyte–matrix interactions. J Bone Joint Surg Am. 1997;79A(4):600–11.
5. Buckwalter JA, Roughley PJ, et al. Age-related changes in cartilage proteoglycans: quantitative electron microscopic studies. Microsc Res Tech. 1994;28(5):398–408.
6. Caliari SR, Weisgerber DW, et al. The influence of collagen–glycosaminoglycan scaffold relative density and microstructural anisotropy on tenocyte bioactivity and transcriptomic stability. J Mech Behav Biomed Mater. 2012;11:27–40.
7. Carrington JL. Aging bone and cartilage: cross-cutting issues. Biochem Biophys Res Commun. 2005;328(3):700–8.
8. Coutts RD, Healey RM, et al. Matrices for cartilage repair. Clinical Orthopaedics and Related Research. 2001;391:S271–9.
9. Davies LC, Blain EJ, et al. The potential of IGF-1 and TGFbeta1 for promoting “adult” articular cartilage repair: an in vitro study. Tissue Eng A. 2008;14(7):1251–61.
10. Elisseeff J, McIntosh W, et al. Controlled-release of IGF-I and TGF-beta1 in a photopolymerizing hydrogel for cartilage tissue engineering. J Orthop Res. 2001;19(6):1098–104.
11. Eviatar T, Kauffman H, et al. Synthesis of insulin-like growth factor binding protein 3 in vitro in human articular cartilage cultures. Arthritis Rheum. 2003;48(2):410–7.
12. Fortier LA, Lust G, et al. Coordinate upregulation of cartilage matrix synthesis in fibrin cultures supplemented with exogenous insulin-like growth factor-I. J Orthop Res. 1999;17(4):467–74.
13. Fortier LA, Nixon AJ, et al. Phenotypic expression of equine articular chondrocytes grown in three-dimensional cultures supplemented with supraphysiologic concentrations of insulin-like growth factor-1. Am J Vet Res. 2002;63(2):301–5.
14. Fosang AJ, Tyler JA, et al. Effect of interleukin-1 and insulin like growth factor-1 on the release of proteoglycan components and hyaluronan from pig articular cartilage in explant culture. Matrix. 1991;11(1):17–24.
15. Frenkel SR, Di Cesare PE. Scaffolds for articular cartilage repair. Ann Biomed Eng. 2004;32(1):26–34.
16. Frisbie DD, Nixon AJ. Insulin-like growth factor 1 and corticosteroid modulation of chondrocyte metabolic and mitogenic activities in interleukin 1-conditioned equine cartilage. Am J Vet Res. 1997;58(5):524–30.
17. Holland TA, Tabata Y, et al. Dual growth factor delivery from degradable oligo(poly(ethylene glycol) fumarate) hydrogel scaffolds for cartilage tissue engineering. J Control Release. 2005;101(1–3):111–25.
18. Howard DA, Shepherd JH, et al. Release of growth factors from a reinforced collagen GAG matrix supplemented with platelet rich plasma: influence on cultured human meniscal cells. J Orthop Res. 2014;32(2):273–8.
19. Hortensius RA, Harley BA. The use of bioinspired alterations in the glycosaminoglycan content of collagen–GAG scaffolds to regulate cell activity. Biomaterials. 2013;34(31):7645–52.
20. Hsu WC, Spilker MH, et al. Inhibition of conjunctival scarring and contraction by a porous collagen–glycosaminoglycan implant. Invest Ophthalmol Vis Sci. 2000;41(9):2404–11.
21. Hulth A, Lindberg L, et al. Mitosis in human osteoarthritic cartilage. Clin Orthop Relat Res. 1972;84:197–9.
22. Hunziker EB. Articular cartilage repair: basic science and clinical progress. a review of the current status and prospects. Osteoarthritis and Cartilage. 2002;10(6):432–63.
23. Ikada Y. Challenges in tissue engineering. J R Soc Interface. 2006;3(10):589–601.
24. Kolettas E, Muir HI, et al. Chondrocyte phenotype and cell survival are regulated by culture conditions and by specific cytokines through the expression of Sox-9 transcription factor. Rheumatology (Oxford). 2001;40(10):1146–56.
25. LeBaron RG, Athanasiou KA. Ex vivo synthesis of articular cartilage. Biomaterials. 2000;21(24):2575–87.
26. Lindahl A, Isgaard J, et al. Growth hormone in vivo potentiates the stimulatory effect of insulin-like growth factor-1 in vitro on colony formation of epiphyseal chondrocytes isolated from hypophysectomized rats. Endocrinology. 1987;121(3):1070–5.
27. Lo MY, Kim HT. Chondrocyte apoptosis induced by hydrogen peroxide requires caspase activation but not mitochondrial pore transition. J Orthop Res. 2004;22(5):1120–5.
28. Loeser RF, Shanker G. Autocrine stimulation by insulin-like growth factor 1 and insulin-like growth factor 2 mediates chondrocyte survival in vitro. Arthritis Rheum. 2000;43(7):1552–9.
29. Luyten FP, Hascall VC, et al. Insulin-like growth factors maintain steady-state metabolism of proteoglycans in bovine articular cartilage explants. Arch Biochem Biophys. 1988;267(2):416–25.
30. Mankin HJ, Dorfman H, et al. Biochemical and metabolic abnormalities in articular cartilage from osteo-arthritic human hips. II. Correlation of morphology with biochemical and metabolic data. J Bone Joint Surg Am. 1971;53(3):523–37.
31. Martin JA, Brown TD, et al. Chondrocyte senescence, joint loading and osteoarthritis. Clin Orthop Relat Res. 2004;427(Suppl):S96–103.
32. Martin JA, Buckwalter JA. Aging, articular cartilage chondrocyte senescence and osteoarthritis. Biogerontology. 2002;3(5):257–64.
33. Martin JA, Buckwalter JA. The role of chondrocyte senescence in the pathogenesis of osteoarthritis and in limiting cartilage repair. J Bone Joint Surg Am. 2003;85-A(Suppl 2):106–10.
34. Madry HA, Kaul GA, et al. Cartilage constructs engineered from chondrocytes overexpressing IGF-I improve the repair of osteochondral defects in a rabbit model. Eur Cells Mater. 2012;25:229–47.
35. Meaney Murray M, Rice K, et al. The effect of selected growth factors on human anterior cruciate ligament cell interactions with a three-dimensional collagen–GAG scaffold. J Orthop Res. 2003;21(2):238–44.
36. Middleton JF, Tyler JA. Upregulation of insulin-like growth factor I gene expression in the lesions of osteoarthritic human articular cartilage. Ann Rheum Dis. 1992;51(4):440–7.
37. Mow VC, Ratcliffe A, et al. Cartilage and diarthrodial joints as paradigms for hierarchical materials and structures. Biomaterials. 1992;13(2):67–97.
38. Mullen LM, Best SM, et al. Binding and release characteristics of insulin-like growth factor-1 from a collagen–glycosaminoglycan scaffold. Tissue Eng C. 2009;16(6):1439–48.
39. Nilsson A, Carlsson B, et al. Regulation by GH of insulin-like growth factor-I mRNA expression in rat epiphyseal growth plate as studied with in situ hybridization. J Endocrinol. 1990;125(1):67–74.
40. Nixon AJ, Fortier LA, et al. Enhanced repair of extensive articular defects by insulin-like growth factor-I-laden fibrin composites. J Orthop Res. 1999;17(4):475–87.
41. O’Brien FJ, Harley BA, et al. The effect of pore size on cell adhesion in collagen–GAG scaffolds. Biomaterials. 2005;26(4):433–41.
42. Oberbauer AM, Peng R. Growth hormone and IGF-I stimulate cell function in distinct zones of the rat epiphyseal growth plate. Connect Tissue Res. 1995;31(3):189–95.
43. Olney RC, Tsuchiya K, et al. Chondrocytes from osteoarthritic cartilage have increased expression of insulin-like growth factor I (IGF-I) and IGF-binding protein-3 (IGFBP-3) and -5, but not IGF-II or IGFBP-4. J Clin Endocrinol Metab. 1996;81(3):1096–103.
44. Rabkin-Aikawa E, Mayer JE Jr, et al. Heart valve regeneration. Adv Biochem Eng Biotechnol. 2005;94:141–79.
45. Ramamurthy P, Hocking AM, et al. Recombinant decorin glycoforms—purification and structure. J Biol Chem. 1996;271(32):19578–84.
46. Reddi AH. Symbiosis of biotechnology and biomaterials: applications in tissue engineering of bone and cartilage. J Cell Biochem. 1994;56(2):192–5.
47. Schmidt MB, Chen EH, et al. A review of the effects of insulin-like growth factor and platelet derived growth factor on in vivo cartilage healing and repair. Osteoarthr Cartil. 2006;14(5):403–12.
48. Schneiderman R, Snir E, et al. Insulin-like growth factor-I and its complexes in normal human articular cartilage: studies of partition and diffusion. Arch Biochem Biophys. 1995;324(1):159–72.
49. Tallheden T, Bengtsson C, et al. Proliferation and differentiation potential of chondrocytes from osteoarthritic patients. Arthritis Res Ther. 2005;7(3):R560–8.
50. Trippel SB, Corvol MT, et al. Effect of somatomedin-C/insulin-like growth factor I and growth hormone on cultured growth plate and articular chondrocytes. Pediatr Res. 1989;25(1):76–82.
51. Tuncel M, Halici M, et al. Role of insulin like growth factor-I in repair response in immature cartilage. Knee. 2005;12(2):113–9.
52. Tyler JA. Insulin-like growth factor 1 can decrease degradation and promote synthesis of proteoglycan in cartilage exposed to cytokines. Biochem J. 1989;260(2):543–8.
53. van der Kraan PM, Buma P, et al. Interaction of chondrocytes, extracellular matrix and growth factors: relevance for articular cartilage tissue engineering. Osteoarthritis and Cartilage. 2002;10(8):631–7.
54. van Susante JL, Buma P, et al. Responsiveness of bovine chondrocytes to growth factors in medium with different serum concentrations. J Orthop Res. 2000;18(1):68–77.
55. Williams DF. The Williams dictionary of biomaterials. Liverpool: Liverpool University Press; 1999.
56. Yannas IV, Tzeranis DS, et al. Biologically active collagen-based scaffolds: advances in processing and characterization. Philos Transact A Math Phys Eng Sci. 1917;368:2123–39.